8-K - Opus Genetics, Inc. - 5.07

Form 8-K - Current report: SEC Accession No. 0001140361-26-015990

Filing Date: 2026-04-22

Accepted: 2026-04-22 06:02:10

Documents: 11

Period of Report: 2026-04-20

Items: Item 5.07: Submission of Matters to a Vote of Security Holders

Opus Genetics, Inc. (Filer) CIK : 0001228627 (see all company filings) EIN. : 113516358 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 26881168 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | ef20071112_8k.htm iXBRL | 8-K

2 | XBRL TAXONOMY EXTENSION SCHEMA | ird-20260420.xsd | EX-101.SCH

3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | ird-20260420_lab.xml | EX-101.LAB

4 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | ird-20260420_pre.xml | EX-101.PRE